Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GNE-493

🥰Excellent
Catalog No. T7166Cas No. 1033735-94-2

GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR,respectively.

GNE-493

GNE-493

🥰Excellent
Purity: 98%
Catalog No. T7166Cas No. 1033735-94-2
GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR,respectively.
Pack SizePriceAvailabilityQuantity
1 mg$41In Stock
5 mg$106In Stock
10 mg$172In Stock
25 mg$363In Stock
50 mg$579In Stock
100 mg$892In Stock
1 mL x 10 mM (in DMSO)$117In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "GNE-493"

Select Batch
Purity:98%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR,respectively.
Targets&IC50
PI3Kγ:16 nM , mTOR:32 nM, PI3Kα:3.4 nM , PI3Kδ:16 nM , PI3Kβ:12 nM
In vivo
GNE-493 was tested in a human MCF7.1 breast cancer xenograft model with a PI3Kα activating mutation. Mice with xenografts received a daily oral dose of 10 mg/kg of GNE-493 for 21 continuous days. Comparable to results in the PC3 prostate cancer model, this treatment led to a 73% inhibition of tumor growth by day 21 compared to control. With similar drug exposure levels, GNE-493 demonstrated equivalent suppression of the PI3K pathway and, thus, comparable efficacy against MCF7.1 breast tumors.
Chemical Properties
Molecular Weight372.44
FormulaC17H20N6O2S
Cas No.1033735-94-2
SmilesCC(C)(O)c1cc2nc(nc(N3CCOCC3)c2s1)-c1cnc(N)nc1
Relative Density.1.408 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (120.82 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6850 mL13.4250 mL26.8500 mL134.2498 mL
5 mM0.5370 mL2.6850 mL5.3700 mL26.8500 mL
10 mM0.2685 mL1.3425 mL2.6850 mL13.4250 mL
20 mM0.1342 mL0.6712 mL1.3425 mL6.7125 mL
50 mM0.0537 mL0.2685 mL0.5370 mL2.6850 mL
100 mM0.0268 mL0.1342 mL0.2685 mL1.3425 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GNE-493 | purchase GNE-493 | GNE-493 cost | order GNE-493 | GNE-493 chemical structure | GNE-493 in vivo | GNE-493 formula | GNE-493 molecular weight